Laura Barbolini, Arnaud Riat, Christian Van Delden, Jacques Schrenzel
{"title":"在CSF中使用1,3,β- d -葡聚糖作为白色念珠菌脑膜炎的生物标志物时要谨慎。","authors":"Laura Barbolini, Arnaud Riat, Christian Van Delden, Jacques Schrenzel","doi":"10.1016/j.ijid.2022.06.033","DOIUrl":null,"url":null,"abstract":"<p><p>Relying on a biomarker to diagnose or follow up the treatment of a Candida albicans meningitis would have an impact on patient management. The biomarker 1,3, β-D-glucan (BDG), developed for serum testing, shows inconsistent values when applied on cerebrospinal fluid (CSF), and its use with the current protocol on CSF samples warrants caution.</p>","PeriodicalId":505767,"journal":{"name":"International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","volume":" ","pages":"531-533"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Caution when using 1,3, β-D-glucan in the CSF as a biomarker of Candida albicans meningitis.\",\"authors\":\"Laura Barbolini, Arnaud Riat, Christian Van Delden, Jacques Schrenzel\",\"doi\":\"10.1016/j.ijid.2022.06.033\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Relying on a biomarker to diagnose or follow up the treatment of a Candida albicans meningitis would have an impact on patient management. The biomarker 1,3, β-D-glucan (BDG), developed for serum testing, shows inconsistent values when applied on cerebrospinal fluid (CSF), and its use with the current protocol on CSF samples warrants caution.</p>\",\"PeriodicalId\":505767,\"journal\":{\"name\":\"International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases\",\"volume\":\" \",\"pages\":\"531-533\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ijid.2022.06.033\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/6/26 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijid.2022.06.033","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/26 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
依靠生物标志物诊断或随访治疗白色念珠菌脑膜炎将对患者管理产生影响。用于血清检测的生物标志物1,3 β- d -葡聚糖(BDG)在应用于脑脊液(CSF)时显示出不一致的值,其与CSF样本的当前方案一起使用需要谨慎。
Caution when using 1,3, β-D-glucan in the CSF as a biomarker of Candida albicans meningitis.
Relying on a biomarker to diagnose or follow up the treatment of a Candida albicans meningitis would have an impact on patient management. The biomarker 1,3, β-D-glucan (BDG), developed for serum testing, shows inconsistent values when applied on cerebrospinal fluid (CSF), and its use with the current protocol on CSF samples warrants caution.